rs5110
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common in clinvar |
| Make rs5110(G;T) |
| Make rs5110(T;T) |
| Reference | GRCh38 38.1/142 |
| Chromosome | 11 |
| Position | 116820918 |
| Gene | APOA4 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs5110 |
| dbSNP (classic) | rs5110 |
| ClinGen | rs5110 |
| ebi | rs5110 |
| HLI | rs5110 |
| Exac | rs5110 |
| Gnomad | rs5110 |
| Varsome | rs5110 |
| LitVar | rs5110 |
| Map | rs5110 |
| PheGenI | rs5110 |
| Biobank | rs5110 |
| 1000 genomes | rs5110 |
| hgdp | rs5110 |
| ensembl | rs5110 |
| geneview | rs5110 |
| scholar | rs5110 |
| rs5110 | |
| pharmgkb | rs5110 |
| gwascentral | rs5110 |
| openSNP | rs5110 |
| 23andMe | rs5110 |
| SNPshot | rs5110 |
| SNPdbe | rs5110 |
| MSV3d | rs5110 |
| GWAS Ctlg | rs5110 |
| GMAF | 0.03306 |
| Max Magnitude | 0 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
| ClinVar | |
|---|---|
| Risk | rs5110(T;T) |
| Alt | rs5110(T;T) |
| Reference | Rs5110(G;G) |
| Significance | Pathogenic |
| Disease | APOLIPOPROTEIN A-IV POLYMORPHISM |
| Variation | info |
| Gene | APOA4 |
| CLNDBN | APOLIPOPROTEIN A-IV POLYMORPHISM, APOA4*1/APOA4*2 |
| Reversed | 1 |
| HGVS | NC_000011.9:g.116691634C>A |
| CLNSRC | OMIM Allelic Variant |
| CLNACC | RCV000019494.2, |
The apolipoprotein A-IV polymorphism rs5110 is also known as c.1140G>T, p.Gln380His and Q360H.
[PMID 18513389
] New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.
[PMID 19041386] Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
[PMID 19057464] Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
[PMID 19131662] A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.
[PMID 19263529] Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
